A podcast for people with Neurofibromatosis (NF-1, NF2-SWN, and Schwannomatosis)--and the people who care for them.
…
continue reading
Interviews with authors of articles from JAMA Dermatology. JAMA Dermatology covers research on the skin, its diseases, and their treatment. Our mission is to explicate the structure and function of the skin and its diseases and the art of using this information to deliver optimal medical and surgical care to the patient. We attempt to enhance the understanding of cutaneous pathophysiology and improve the clinician's ability to diagnose and treat skin disorders.
…
continue reading
Welcome to touchPODCAST where you can listen and learn from our expert faculty, hand-picked from the Touch Medical Media family of independent medical websites. Educating physicians on a fully global scale since 2005! We make positive changes to clinical practice, with the ultimate objective of improving patient and community health. Working alongside leading medical experts, societies and industry, our mission is to provide practical, expert opinions to support best practices for busy Healt ...
…
continue reading
Welcome to the Rights Upfront Podcast, where every story finds a voice. Join us as we delve into the world of disability rights and inclusion, amplifying diverse voices and advocating for change. From personal experiences to expert insights, each episode explores the challenges, triumphs, and ongoing efforts to promote equality and accessibility for all. Whether you're passionate about disability rights or simply curious to learn more, tune in to be inspired, informed, and empowered. Join th ...
…
continue reading
Explore the myths, mysteries, and medical breakthroughs of the most complex and powerful organ in your body – your brain. Weaving together expert interviews with heartfelt, inspiring snapshots of the patients and family members in the middle of it all, Heather Sherman dives into the latest science on Alzheimer’s, Parkinson’s, epilepsy, stroke, concussion, spinal cord injury, brain cancer, chronic pain and other brain diseases and disorders. Along the way she uncovers surprising insights, she ...
…
continue reading

1
The Role of Formulation in Benzene Formation in Benzoyl Peroxide Products
19:14
19:14
Play later
Play later
Lists
Like
Liked
19:14Interview with John S. Barbieri, MD, MBA, and Michelle Wong, PhD, authors of The Role of Formulation in Benzene Formation in Benzoyl Peroxide Products. Hosted by Adewole S. Adamson, MD. Related Content: The Role of Formulation in Benzene Formation in Benzoyl Peroxide Products
…
continue reading

1
Updates in BCMA-directed therapies in multiple myeloma from ASH 2024
55:57
55:57
Play later
Play later
Lists
Like
Liked
55:57touchCONGRESS for ONCOLOGY Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition. Prof. Weisel is then joined by fellow experts Dr Nisha Joseph and Prof. Roman Hájek to discuss the potential implications of …
…
continue reading

1
RAS mutations and personalized cancer care: Targeting the future
31:02
31:02
Play later
Play later
Lists
Like
Liked
31:02touchEXPERT OPINIONS for touchONCOLOGY Listen to a medical oncologist, a pancreatic cancer specialist and a lung cancer specialist discuss the role of RAS mutations in solid tumours, notably pancreatic cancer and NSCLC, and how they may be therapeutically targeted to improve patient outcomes. The experts Dr David S Hong, The University of Texas MD …
…
continue reading

1
Superficial Curettage Plus Imiquimod Cream for Nodular Basal Cell Carcinoma
16:42
16:42
Play later
Play later
Lists
Like
Liked
16:42Interview with Babette J. A. Verkouteren, MD, PhD, author of Imiquimod Cream Preceded by Superficial Curettage vs Surgical Excision for Nodular Basal Cell Carcinoma: A Secondary Analysis of a Randomized Clinical Trial. Hosted by Adewole S. Adamson, MD. Related Content: Imiquimod Cream Preceded by Superficial Curettage vs Surgical Excision for Nodul…
…
continue reading

1
What’s new in primary ITP? Key updates from ASH 2024
40:35
40:35
Play later
Play later
Lists
Like
Liked
40:35touchPANEL DISCUSSION for touchONCOLOGY Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exp…
…
continue reading

1
Focused insights: Data implications of ADCs in NSCLC treatment
21:54
21:54
Play later
Play later
Lists
Like
Liked
21:54touchFOCUS for touchRESPIRATORY Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety data for ADCs in the treatment of patients with NSCLC in the first- and second-line setting, and place these data in the context of current standards of care. She also considers how these dat…
…
continue reading

1
Collaboration in chronic ITP: Improving quality of life and patient outcomes - touchSYMPOSIUM for touchONCOLOGY
1:20:58
1:20:58
Play later
Play later
Lists
Like
Liked
1:20:58touchSYMPOSIUM for touchHAEMATOLOGY Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, CA, USA. Symposium chair Prof. Cindy Neunert is joined by Dr María Eva Mingot Castellano and Prof. David Kuter to discuss the impact of immune thrombocytopenia…
…
continue reading

1
Collaboration in chronic ITP: Improving quality of life and patient outcomes - touchSYMPOSIUM for touchHAEMATOLOGY
1:20:58
1:20:58
Play later
Play later
Lists
Like
Liked
1:20:58touchSYMPOSIUM for touchHAEMATOLOGY Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, CA, USA. Symposium chair Prof. Cindy Neunert is joined by Dr María Eva Mingot Castellano and Prof. David Kuter to discuss the impact of immune thrombocytopenia…
…
continue reading

1
Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchONCOLOGY
37:37
37:37
Play later
Play later
Lists
Like
Liked
37:37touchEXPERT FOCUS for touchONCOLOGY Listen to three experts provide insights into the optimal management of neurofibromatosis type 1 (NF1) in paediatric and adult patients, with a focus on plexiform neurofibromas (PNs). Strategies for ensuring the smooth transitioning of paediatric patients into the adult care system are also considered. The expert…
…
continue reading

1
Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchNEUROLOGY
37:38
37:38
Play later
Play later
Lists
Like
Liked
37:38touchEXPERT FOCUS for touchNEUROLOGY Listen to three experts provide insights into the optimal management of neurofibromatosis type 1 (NF1) in paediatric and adult patients, with a focus on plexiform neurofibromas (PNs). Strategies for ensuring the smooth transitioning of paediatric patients into the adult care system are also considered. The exper…
…
continue reading

1
Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age
16:57
16:57
Play later
Play later
Lists
Like
Liked
16:57Interview with Lauren A. V. Orenstein, MD, MSc, author of Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age. Hosted by Adewole S. Adamson, MD. Related Content: Outpatient Dermatology Productivity Measures by Patient Race, Sex, and Age
…
continue reading

1
Advancing the treatment of muscle-invasive bladder cancer: Updates on immunotherapy in the perioperative setting
38:15
38:15
Play later
Play later
Lists
Like
Liked
38:15touchEXPERT OPINIONS for touchONCOLOGY Listen to an oncologist, urologist and oncology nurse highlight the key data for immunotherapy in the perioperative setting for muscle-invasive bladder cancer, practical considerations for its use in clinical practice, and how possible side effects can be monitored for and managed. They also consider the role …
…
continue reading

1
Navigating treatment choices in high-risk early-stage melanoma - touchDERMATOLOGY
34:20
34:20
Play later
Play later
Lists
Like
Liked
34:20touchEXPERT OPINIONS for touchDERMATOLOGY Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions. The experts Dr Tina J Hieken, Mayo Clini…
…
continue reading

1
Navigating treatment choices in high-risk early-stage melanoma - touchONCOLOGY
34:19
34:19
Play later
Play later
Lists
Like
Liked
34:19touchEXPERT OPINIONS for touchONCOLOGY Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions. The experts Dr Tina J Hieken, Mayo Clinic, …
…
continue reading

1
Overcoming Barriers: Patrice's Journey of Resilience, Growth, and Self-Empowerment
12:16
12:16
Play later
Play later
Lists
Like
Liked
12:16Navigating the world while living with a learning disability and a hearing impairment is no easy feat, but Patrise's journey is nothing short of inspiring. From her early struggles with memory and requiring support for everyday tasks to overcoming barriers in education and employment, Patrise shares her story of resilience and determination. Her ca…
…
continue reading

1
Advances in IOL technology and power calculations: Updates and innovations from 2024
13:58
13:58
Play later
Play later
Lists
Like
Liked
13:58touchFOCUS for touchOPHTHALMOLOGY Listen to Dr John Ladas, an expert in cataract surgery, as he answers a series of questions on intraocular lens power calculation, including how the use of artificial intelligence may help to improve accuracy, and provides an update on the latest advances in intraocular lens technology. The expert Dr John Ladas, Ma…
…
continue reading

1
Supporting healing in epidermolysis bullosa: Innovations and new directions for care
18:55
18:55
Play later
Play later
Lists
Like
Liked
18:55touchFOCUS for touchDERMATOLOGY Listen to Prof. Amy Paller as she answers a series of questions on the key features of epidermolysis bullosa, including its pathophysiology and clinical manifestations. In addition, she responds to questions on the role of new and emerging topical therapies for epidermolysis bullosa in patient care, with a focus on a…
…
continue reading

1
From Fatigued to Focussed: A Cancer Survivor's Journey with Sleep Apnea
12:47
12:47
Play later
Play later
Lists
Like
Liked
12:47In this bonus episode, we delve into the life-changing journey of Carmen Chu, a cancer survivor and mother who was diagnosed with sleep apnea. Carmen shares her struggles with interrupted sleep, fatigue, and the impact on her daily life. She discusses her experience with sleep tests and the transformative benefits of using a CPAP machine. Additiona…
…
continue reading
This is officially the end of Season 1. Thanks everyone, see you in 2025 for Season 2! Thanks to our monthly supporters Annette B. Rosemary AndersonBy Shane Smith
…
continue reading

1
Primary biliary cholangitis: Appraising the changing therapeutic landscape
35:31
35:31
Play later
Play later
Lists
Like
Liked
35:31touchEXPERT OPINIONS for touchIMMUNOLOGY Listen to a leading expert in hepatology as they explore the current and future management of primary biliary cholangitis. The expert Dr Mitchell Shiffman - Bon Secours Liver Institute, Richmond, VA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational grant f…
…
continue reading

1
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 4
13:46
13:46
Play later
Play later
Lists
Like
Liked
13:46touchMDT for touchONCOLOGY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Me…
…
continue reading

1
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 3
16:05
16:05
Play later
Play later
Lists
Like
Liked
16:05touchMDT for touchONCOLOGY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Me…
…
continue reading

1
touchMDT for touchRESPIRATORY - What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)?
15:14
15:14
Play later
Play later
Lists
Like
Liked
15:14touchMDT for touchRESPIRATORY What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)? Listen to key experts Prof. Suresh Senan, Dr Lizza Hendriks and Dr Jacob Sands discuss the impact of ICIs on the real-world management of patients with LS-SCLC, including guidanc…
…
continue reading

1
touchMDT for touchRESPIRATORY - What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)?
13:57
13:57
Play later
Play later
Lists
Like
Liked
13:57touchMDT for touchRESPIRATORY What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)? Listen to experts Dr Jacob Sands and Prof. Suresh Senan discuss the latest data for ICIs in LS-SCLC, including data released at key congresses in 2024, and share their clinical insights. The…
…
continue reading

1
touchMDT for touchRESPIRATORY - What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)?
14:53
14:53
Play later
Play later
Lists
Like
Liked
14:53touchMDT for touchRESPIRATORY What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)? Listen to experts Dr Lizza Hendriks and Prof. Suresh Senan discuss the rationale for using ICIs in LS-SCLC, including relevant evidence from clinical trials in extended-stage SCLC and LS-SCLC, and revi…
…
continue reading

1
touchMDT for touchONCOLOGY - What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)?
15:14
15:14
Play later
Play later
Lists
Like
Liked
15:14touchMDT for touchONCOLOGY What impact could immune checkpoint inhibitors (ICIs) have on the management of patients with limited-stage small cell lung cancer (LS-SCLC)? Listen to key experts Prof. Suresh Senan, Dr Lizza Hendriks and Dr Jacob Sands discuss the impact of ICIs on the real-world management of patients with LS-SCLC, including guidance o…
…
continue reading

1
touchMDT for touchONCOLOGY - What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)?
13:57
13:57
Play later
Play later
Lists
Like
Liked
13:57touchMDT for touchONCOLOGY What are the key data for immune checkpoint inhibitors (ICIs) in the treatment of limited-stage small cell lung cancer (LS-SCLC)? Listen to experts Dr Jacob Sands and Prof. Suresh Senan discuss the latest data for ICIs in LS-SCLC, including data released at key congresses in 2024, and share their clinical insights. The mu…
…
continue reading

1
touchMDT for touchONCOLOGY - What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)?
14:53
14:53
Play later
Play later
Lists
Like
Liked
14:53touchMDT for touchONCOLOGY What is the rationale for using immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC)? Listen to experts Dr Lizza Hendriks and Prof. Suresh Senan discuss the rationale for using ICIs in LS-SCLC, including relevant evidence from clinical trials in extended-stage SCLC and LS-SCLC, and review …
…
continue reading

1
"I felt...a very electric shock": One Woman's Story of Extreme Facial Pain
16:07
16:07
Play later
Play later
Lists
Like
Liked
16:07In this bonus episode, we share Adriana Salazar's powerful and emotional journey. Adriana, a 40-year-old mother and wife, first experienced the pain on her honeymoon in Portugal. The pain disappeared but returned during her pregnancy, escalating to a point where she couldn't smile or eat. Despite seeing multiple specialists, she received her diagno…
…
continue reading

1
Vaccination strategies for pneumococcal disease
33:06
33:06
Play later
Play later
Lists
Like
Liked
33:06touchEXPERT OPINIONS for touchINFECTIOUS DISEASES In this activity, Prof. Antoni Torres, a leading expert in respiratory infections, discusses the burden of pneumococcal disease in vulnerable patient populations, the evolving landscape of Streptococcus pneumoniae subtypes and the role that next-generation vaccines can play in preventing severe pneu…
…
continue reading

1
Epilepsy and Motherhood: One Mom’s Journey
17:26
17:26
Play later
Play later
Lists
Like
Liked
17:26Today, we’re diving into the deeply personal journey of Julianne Hazelwood, a journalist and new mother, who has lived with epilepsy since her early teenage years. Julianne shares her transformational experience of motherhood, the challenges of managing epilepsy, and how The Lullaby Project—a group that brings together expectant mothers with songwr…
…
continue reading

1
Optimizing treatment of CML in the first-line setting and beyond: Insights from EHA 2024 and ESH-iCMLf 2024
52:36
52:36
Play later
Play later
Lists
Like
Liked
52:36touchCONGRESS for touchONCOLOGY Listen to Prof. Gianantonio Rosti, an expert in CML, as he reviews key data presented at the 2024 EHA Hybrid congress and the ESH-iCMLf 26th Annual John Goldman Conference, on tyrosine kinase inhibitors (TKIs) for treating chronic myeloid leukaemia (CML) in the first-and later-line settings. Prof. Rosti is then joine…
…
continue reading

1
Pharmacological management of agitation in Alzheimer's dementia
34:28
34:28
Play later
Play later
Lists
Like
Liked
34:28touchPANEL DISCUSSION for touchNEUROLOGY Listen to a panel of leading experts discuss best practice in the management of agitation in Alzheimer’s dementia and the potential of new pharmacological approaches that target aspects of the underlying pathophysiology. The experts Prof. Jeffrey Cummings, University of Nevada, Las Vegas, NV, USA Prof. Krist…
…
continue reading

1
touchIN CONVERSATION - Pulmonary arterial hypertension: A practical roadmap from diagnosis to treatment - touchCARDIO
35:33
35:33
Play later
Play later
Lists
Like
Liked
35:33touchIN CONVERSATION for touchCARDIO Listen to Prof. Manreet Kanwar in conversation with Prof. Jean-Luc Vachiéry, two experts in pulmonary arterial hypertension who are practicing in the USA and Belgium, respectively. They respond to questions submitted by the HCP audience and provide expert insights into the diagnosis of pulmonary arterial hyperte…
…
continue reading

1
touchIN CONVERSATION - Pulmonary arterial hypertension: A practical roadmap from diagnosis to treatment - touchRESPIRATORY
35:33
35:33
Play later
Play later
Lists
Like
Liked
35:33touchIN CONVERSATION for touchRESPIRATORY Listen to Prof. Manreet Kanwar in conversation with Prof. Jean-Luc Vachiéry, two experts in pulmonary arterial hypertension who are practicing in the USA and Belgium, respectively. They respond to questions submitted by the HCP audience and provide expert insights into the diagnosis of pulmonary arterial hy…
…
continue reading

1
Hidradenitis Suppurativa and Maternal and Offspring Outcomes
17:37
17:37
Play later
Play later
Lists
Like
Liked
17:37Interview with Nathalie Auger, MD, MSc, and Vincent Piguet, MD, PhD, authors of Hidradenitis Suppurativa and Maternal and Offspring Outcomes. Hosted by Adewole S. Adamson, MD. Related Content: Hidradenitis Suppurativa and Maternal and Offspring Outcomes
…
continue reading

1
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 1
14:12
14:12
Play later
Play later
Lists
Like
Liked
14:12touchMDT for touchONCOLOGY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Me…
…
continue reading

1
touchMDT: Precision targeting of MET in NSCLC: A multidisciplinary approach - Discussion 2
15:59
15:59
Play later
Play later
Lists
Like
Liked
15:59touchMDT for touchONCOLOGY Listen to a panel of experts discuss the use of targeted therapies for NSCLC with MET alterations. The multidisciplinary team Thoracic medical oncologist: Dr Xiuning Le, University of Texas MD Anderson Cancer Center, Houston, TX, USA Interventional pulmonologist: Dr Christine Argento, Johns Hopkins University School of Me…
…
continue reading